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M
ycotic keratitis, commonly known as fungal keratitis, accounts for approximately 1% to 44% of all cases of microbial keratitis, depending on the geographic location. 1, 2 The genera that commonly cause infection of the cornea include Fusarium, Aspergillus, Curvularia, Bipolaris, and Candida. [1] [2] [3] Among the Candida species, Candida albicans is the most common etiologic agent of keratitis. 4 In this form of keratitis, one or more ocular (e.g., insufficient tear secretion, defective eyelid closure) or systemic (e.g., diabetes mellitus, immunosuppression) conditions predispose to the infection. This form of mycotic infection also may supervene on a preexisting epithelial defect due to herpes keratitis or due to abrasions caused by contaminated contact lenses. 5 Management of fungal keratitis largely involves a decision on which antifungal to use and the route of administration. Most of the currently available antifungal medications have limitations, such as poor bioavailability and limited ocular penetration, especially in cases with deep-seated lesions. [6] [7] [8] These factors, particularly especially in cases of severe fungal keratitis, account for the slow resolution of fungal infections, with most cases finally requiring a therapeutic penetrating keratoplasty (PKP). 8 Clinically, the commercially available Natamycin 5% suspension is the initial drug of choice for fungal keratitis. If worsening of the keratitis is observed on topical Natamycin, Amphotericin B (amp B) can be substituted, although topical azoles (e.g., fluconazole [FLC] and voriconazole) are considered to be a good alternative to amp B for the treatment of Candida keratitis. They have better ocular penetration and are less toxic to the corneal epithelium, compared with amp B. [9] [10] [11] The clinician must determine the length of treatment for each case based on clinical response and experience. Treatment with a systemic antifungal agent is recommended in cases of severe deep keratitis, scleritis, and endophthalmitis. Systemic antifungals are also used after PKP for fungal keratitis. necessity for long-term usage of antifungal in immunocompromised individuals, causes additional difficulty in treatment. 13 Recent scientific studies have reevaluated old antibiotics, such as chloramphenicol, tetracyclines, and polymyxins, traditionally used for bacterial infections, for their potential antifungal activity. [14] [15] [16] [17] Based on literature and clinical experience, in this study, we evaluated the antifungal activity of a widely used antibacterial ophthalmic combination (Colbiocin; SIFI SpA, Catania, Italy) containing tetracycline (TET), chloramphenicol (CAF), and colistimethate sodium (CS), using in vitro tests and an ex vivo mycotic keratitis model. Specific assays were also carried out to understand the mechanism of action.
MATERIALS AND METHODS

Antimicrobial Agent
Fixed antibiotic combination (AC) (Colbiocin; SIFI SpA) contained CAF (4 mg/mL), TET (5 mg/mL), and CS (14.4 mg/ mL). Fluconazole (FLC) was obtained from Sigma-Aldrich, Milan, Italy; CAF from Química Sintética S.A., Madrid, Spain; TET from Ningxia Qiyuan Pharmaceutical Co., Ningxia, China; and CS from Xellia Pharmaceuticals APS Dalslandsgade, Copenhagen, Denmark.
Strains
The following strains, obtained from Italian hospitals in Messina and Catania, were used for the antimicrobial testing: Candida albicans ATCC 2091, C. albicans ATCC 10231, and 14 clinical isolates of C. albicans (n ¼ 7), Candida glabrata (n ¼ 5), Candida utilis, and Candida tropicalis. The yeasts were stored at -708C in Microbanks vials (DID; Pro-Lab Diagnostics, Ontario, Canada).
In Vitro Study
Antifungal Susceptibility Testing. Drug susceptibility was determined using the Clinical and Laboratory Standards Institute microbroth dilution protocol. 18, 19 Cultures for antifungal activity tests were grown in RPMI-1640 medium supplemented with MOPS (Oxoid, Milan, Italy) at 308C (48 hours).
Working cultures of yeasts were adjusted to the required concentration of 10 3 colony-forming units per milliliter (CFU/ mL). The AC power was reconstituted in 5 mL buffer containing EDTA, Polysorbate 80, and purified water. Dimethyl sulfoxide (DMSO; Sigma-Aldrich) was used to dissolve CAF and TET and then diluted to the highest concentration (1% vol/vol) using RPMI-1640 medium. FLC was dissolved in RPMI-1640 medium. Serial doubling dilutions of the AC and antimicrobial agents were prepared in 96-well microtiter plates over the range of 0.016 to 2 mg/mL in RPMI-1640 medium supplemented with MOPS. The plates were incubated for 48 hours at 358C. Growth controls (medium with inocula) were included. MIC 90 is defined as the minimum inhibitory concentration required to inhibit the growth of 90% of organisms. To determine MFC (defined as the lowest concentration of antimicrobial agents at which 99.9% of microorganisms were killed), broth was taken from each well and inoculated in Sabouraud Dextrose Agar (SDA) for 48 hours at 358C. Each experiment was performed in triplicate.
Checkerboard. The checkerboard broth microdilution assay, a two-dimensional array of serial concentrations of test compounds, was used to assess drug synergism. The minimum inhibitory concentrations (MICs) of each antibiotic included in the AC were determined either individually or in combination for two selected strains: C. albicans ATCC 10231 and C. albicans n. 4 5 CFU/mL. At predetermined time points (0, 2, 4, 6, 8, 10, and 24 hours), a 0.1-mL aliquot was removed from the control tube (drug free) and from the tube with AC or FLC for each strain. Serial dilutions in saline were performed. Volumes of 0.1 mL were spread onto SDA plates and incubated at 358C for 24 to 48 hours to determine the numbers of CFU/mL. All time-kill curve studies were conducted in triplicate.
Propidium Iodide Staining. To analyze the membrane integrity, fraction of surviving cells of C. albicans ATCC 2091 and C. albicans n. 4 exposed to AC and each antibiotic were stained with propidium iodide (PI) solution (Sigma-Aldrich). Control samples of both strains were performed for comparison. Briefly, treated and control cells (10 5 cells/mL) were washed and suspended in PBS (pH 7.0). To this cell suspension, PI solution (stock solution 1 mg/mL) was then added to these cell suspensions that were later incubated for 10 minutes at room temperature. Cells were again washed to remove the excess of the stain and examined under the inverted microscope Axio Observer.Z1 with ApoTome.2 (Zeiss, Milan, Italy).
MitoTracker Staining. To detect permeability changes of mitochondrial membrane, fraction of surviving cells of C. albicans ATCC 2091 and C. albicans n. 4 exposed to AC and each antibiotic were stained with mitochondrion-specific dye MitoTracker RedCMXRos (MTR) (Invitrogen, Fisher Scientific Italia, Rodano-MI, Italy) according to the manufacturer's instructions. Control samples of both strains were performed for comparison. Treated and control cells (10 5 cells/mL) were collected by centrifugation and suspended in fresh medium with the mitochondrion-specific dye MTR at a final concentration of 50 nM. 21, 22 Cells were incubated for 15 minutes at 358C in the dark. Stained cells were washed three times with PBS in the dark and immediately observed using the above-mentioned microscope. MTR has excitation and emission peaks at 579 and 599 nm, respectively.
Ex Vivo Study
Preparation of Inocula. The following strains were used: C. albicans ATCC 2091 and C. albicans n. 4. The yeasts were cultured in RPMI-1640 medium supplemented with MOPS at 358C for 24 hours and then, a few colonies of each strain were washed three times with PBS to reach a density of 5 3 10 8 CFU/ mL (V-1200-VWR, Milan, Italy) and then diluted to a final concentration of the inoculum (5 3 10 4 CFU/mL). Rabbit Globe Harvest. Normal rabbit eyes, obtained from a local abattoir, were enucleated immediately following Combination Antibiotic Therapy for Fungal Keratitis IOVS j August 2017 j Vol. 58 j No. 10 j 4293 euthanization, washed before with 1% povidone, rinsed with saline, and after submerged in tubes with 0.1% Dulbecco's Modified Eagle's Medium (DMEM Ham's F-12; PAA Laboratories, Biolife, Milan, Italy). The tubes, placed in a container with ice for preservation, were transported to the laboratory and used immediately. C. albicans Growth Curve. The growth curves of C. albicans ATCC 2091 and C. albicans n. 4 ocular isolates were assessed using a modified ex vivo keratitis model. 23 The eyes were randomly divided into two groups (20 corneas per group) corresponding to each C. albicans strain. For each group, the eyes were intrastromally injected with 50 lL of the yeast suspension (5 3 10 4 CFU/mL) using a 30-gauge needle. Then the groups were divided into five subgroups (four eyes each) according to growth curve times (0, 12, 24, 48, and 72 hours from the insult). The sclero-corneal ring of each eye was excised using curved scissors and placed on the corneal support in dishes containing 2.5 mL DMEM as previously described. 24, 25 The organ cultures were incubated at 378C in humidified atmosphere of 6% CO 2 . To moisten the epithelium, 100 lL medium was added drop wise to the surface of the corneal epithelium every 12 hours. The culture medium in the dishes was changed every 24 hours. At established fixed times, corneas without scleral ring were individually weighed and homogenized in 1 mL saline at 48C for 30 seconds; the homogenate was serially diluted (1:10 dilution) in saline, and seeded in duplicate onto SDA. The results were reported to tissue weight and expressed as CFU/g. Treatment of C. albicans Keratitis. Twenty-four enucleated eyes were randomly divided into two groups (12 corneas per group) corresponding to each C. albicans strain. Each group was intrastromally injected with 50 lL yeast suspension containing 5 3 10 4 CFU/mL. At 2 hours following the injection (early-infection phase), the corneas were divided into three groups of four corneas each. The first group was treated with AC, the second group with FLC, and the third control group with PBS. The treatment regimen consisted of six daily instillations (50 lL). Then the tissues, 1 hour later after the last instillation, were homogenized and plated to determine the number of recovered CFU/g.
Statistical Analysis
The results are expressed as means 6 SDs from three experiments and statistically analyzed by a 1-way ANOVA, followed by Tukey posttest by GraphPad Prism Software (San Diego, CA, USA). Differences in groups and treatments were considered significant for P < 0.05.
RESULTS
In Vitro Study
Antifungal Susceptibility Testing. MIC 90 values for the individual antibiotics against all strains of Candida spp. used were higher than those observed for the reference FLC. Among all antibiotics tested, TET was the most efficient (MIC: 250-500 lg/mL). MIC values were detected from the 1:2 to 1:20 dilution of the reconstituted AC (Table 1) .
Checkerboard. C. albicans ATCC 10231 and C. albicans n. 4 clinical isolates were chosen for further assays. In a checkerboard microdilution assay, pairs of antibiotics were tested in combination with each other's antibiotic to determine FICI values. Synergy was observed for all combinations tested on C. albicans ATCC 10231. In particular, CAF þ TET (FICI 0.5), TET þ CS (FICI 0.28), and CAF þ CS (FICI 0.12). Synergy also was observed for the combination CAF þ TET (FICI 0.5) on C. albicans n. 4, whereas additivity (FICI 1) was detected for the other combinations (Table 2) .
Time-Killing Curve. The time-killing curves showed that the AC and FLC, at a concentration of 10 times MIC, were able to maintain under control the growth of C. albicans ATCC 10231 and C. albicans n. 4 up to 10 hours. At 24 hours, the AC was able to reduce the loads of 1 Log 10 CFU/g and 0.8 Log 10 CFU/g, compared to the initial inoculum for the ATCC strain and for the clinical isolate, respectively (Fig. 1) . The differences were statistically significant versus the control, but also versus FLC (P < 0.0001 for C. albicans ATCC 10231, P < 0.001 for C. albicans n. 4).
PI Staining. Propidium iodide, a red-fluorescent nuclear stain, is a membrane impermeant dye that is generally excluded from viable cells. Microscopic examination demonstrated that the cells (approximately 86.7%) of both strains treated with AC (1:10 vol/vol) were stained red probably because they lost cell membrane integrity. The cells (approximately 68.3%) treated with CS (1000 lg/mL) demonstrated the same result, whereas 25.6% of untreated cells lost their membrane permeability (Fig.  2) . Positively stained cells (PI þ ) were observed under inverted fluorescence microscope.
MitoTracker Staining. MitoTracker is a mitochondrionspecific stain in live cells and its accumulation depends on the membrane potential. However, once incorporated in the mitochondria, it can chemically link to thiol groups and will not leave the mitochondria when the membrane potential decreases as a result of fixation and/or cell death. Fluorescence microscope images showed positive staining in mitochondrial networked areas of healthy nontreated cells for both strains. The treated cells (approximately 70%) in the presence of TET (0.5 MIC) or CAF (1000 lg/mL) showed a more diffuse and less intense staining of the mitochondria, indicating that mitochondrial function was reduced but not eliminated. The cells (approximately 90%) treated with AC >2000 500 >2000 2.5 1:10 C. albicans 18 >2000 500 >2000 2.5 1:10 C. albicans 355 >2000 500 >2000 2.5 1:10 C. glabrata 1 >2000 250 >2000 4 1:5 C. glabrata 3 2000 500 >2000 4 1:20 C. glabrata 8 >2000 500 >2000 4 1:2 C. glabrata 9 >2000 500 >2000 4 1:2 C. glabrata 10 >2000 500 >2000 4 1:5 C. utilis >2000 500 >2000 2.5 1:2 C. tropicalis >2000 250 >2000 2. Ex Vivo Study C. albicans Growth Curve. The growth curves of C. albicans ATCC 10231 and C. albicans n. 4 strains were superimposable. The mycotic load obtained from the corneas after intrastromal injection was 3.3 6 0.5 Log 10 CFU/g. After 24 hours from the fungal challenge, the load increased approximately 4 Log 10 CFU/g, remained almost unchanged for up 72 hours, and then decreased (data not shown).
Combination Antibiotic
Treatment of C. albicans Keratitis. The AC was effective in the ex vivo rabbit keratitis experiments in decreasing the load of C. albicans ATCC 10231 and C. albicans n. 4. Therefore, AC significantly reduced the load of both C. albicans strains by 4 Log 10 CFU/g with respect to the control after six doses, up to 24 hours after infection (P < 0.001). Moreover, AC showed higher activity than FLC against C. albicans ATCC 10231 (approximately 1 Log 10 CFU/g) (P < 0.01). Similar efficacy against C. albicans n. 4 was observed (Fig. 4) .
DISCUSSION
Because fungi are eukaryotic cells, they share many pathways with human cells, thus increasing the probability of antifungal activity of ''nonfungal drugs.'' In the past few years, there has been an increased interest in revived antibiotics. Old drugs that have been recently revived include colistin, temocillin, fosfomycin, mecillinam, nitrofurantoin, and chloramphenicol for multidrug-resistant gram-negative bacteria and trimethoprim-sulfamethoxazole for methicillin-resistant Staphylococcus aureus. Among these, colistin and chloramphenicol also demonstrated antifungal activity against yeasts. 14, 15, 21, 26 In this study, we found that CAF, TET, and CS used alone have weak, if any, antifungal activity against several Candida yeasts with respect to FLC, but that this activity is highly enhanced when they were used as AC in fixed combination. The underlying mechanism of each antibiotic against yeasts may be explained as follows: TET and CAF promote mitonuclear protein imbalance and mitochondrial dysfunction, CS binds lipopolysaccharide and anionic phospholipids in the bacterial cell membrane, disrupting membrane integrity. 16, 17 The mechanism of action for tetracycline and its derivative doxycycline is the inhibition of translation through binding to the bacterial 30S ribosomal unit. This specificity for a bacterial component has led to an expectation that tetracycline does not affect eukaryotic cells. However, tetracycline leads to a state of so-called mitonuclear protein imbalance, which disturbs mitochondrial proteostasis and inhibits mitochondria function. The mitonuclear protein imbalance is accompanied by a strong decrease in cellular respiration, indicative for severely impaired mitochondrial activity. 16 Moreover, tetracycline eliminates the diauxic shift. 21 The lack of diauxic shift or the lack of a functional mitochondria alters sterol metabolism resulting in lower ergosterol levels. 27 Chloramphenicol is a known inhibitor of mitochondrial translation in eukaryotes, which binds to the A site and occupies the same position as the aminoacyl-tRNA (aa-tRNA), preventing protein synthesis in prokaryotes. 28 Ribosomal similarities between bacteria and mitochondria may provide the basis for mitochondrial sensitivity to chloramphenicolmediated inhibition of protein synthesis. 29 Expression of the transferritin receptor seems to be the most relevant to the chloramphenicol-mitochondrion interaction. Specifically, chloramphenicol diminishes mitochondrion-based transferritin 
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receptor expression, resulting in ferritin depletion in mitochondria. 30 Polymyxins bind lipopolysaccharide and anionic phospholipids in the gram-negative bacterial cell membrane, disrupting membrane integrity. 17 Polymyxins are cationic cyclic hepatapeptides with a hydrophobic tail that interacts with the bacterial cytoplasmic membrane, therefore changing its permeability and triggering cell death. 26 Weak antifungal activity of colistin and polymyxin B against several fungi has already been reported. [31] [32] [33] As hypothesized by Zhai et al. 14 in 2010, polymyxin B kills fungi through binding anionic lipids on the fungal membrane and disruption of membrane integrity. The lower efficiency of polymyxin alone against eukaryotes compared with bacteria could be partly due to the presence of sterols in the eukaryotic membrane, as sterols have been shown to reduce the insertion of cationic peptides into anionic mixed membranes to form pores.
Moreover, these results indicate that the combination of corneal organ culture and experimental microbial keratitis has the potential to be used as a mechanistically based alternative to in vivo animal testing. Although the ex vivo models lack immune elements, the three-dimensional architecture remains, as do the intracellular innate immune molecules and cellularstromal-components. 34 In conclusion, we showed that AC containing the three antibiotics in fixed combination has a high efficacy against Candida spp., in both in vitro and in ex vivo models. The effect reported can be due to the different modes of action of the three antimicrobial agents used in combination: the CS increases the permeability of the yeast membrane allowing the subsequent penetration of TET and CAF, which alter mitochondrial function.
AC has been widely used on the Italian market and other European countries as an eye drop/ointment to treat bacterial eye infections for 50 years. Based on these results, we can assume that AC has the potential to be used clinically as drug of first choice when the diagnosis of infectious keratitis caused by bacteria or fungi is unclear. Specific diagnostic tests are needed to rule out the condition and, if necessary, progress to appropriate treatment. Further studies are, however, needed on other yeast and mold strains, such as Fusarium and Aspergillus, to extend these findings.
